Create was founded by Daniel Getts in 2020.

Who are Create's investors?

Create's investors include 8VC, Raptor Group, Newpath Partners.

How much funding has Create raised?

Create has disclosed $2M raised across 1 round.

Where is Create headquartered?

Create is headquartered in San Francisco, US.

Create

San Francisco, US · Founded 2020 · Delaware corporation · 3 known investors

Find your way into Create

Paths you didn't know you had: your email and LinkedIn already hold routes to the Create team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

CREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.

Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Create was founded in 2020 by Daniel Getts.

Daniel Getts Founder and CEODaniel Getts is founder and CEO of CREATE Medicines, a clinical-stage biotech company developing in vivo mRNA immune cell programming therapies for cancer, autoimmune disease, and transplant rejection.

Brett KaplanChief Financial and Business Officer

Marcus LoweNamed on SEC filing

Dhruv AminNamed on SEC filing

Investors · 3

8VClisted by 8VCAustin · $500K – $50M

How we know: 8VC's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Raptor Grouplisted by Raptor GroupMiami Beachvia James J. Pallotta · inferred

Newpath PartnersreportedBoston · $50K – $10M

How we know: the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$2M disclosed across 1 round · 2022

▶$2MraisedNov 2022 · 1 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Marcus LoweExecutive Officer, Director
Dhruv AminExecutive Officer, Director

Offering amount: $3M
Amount sold: $2M
First sale: Nov 2022
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Create went on to found or lead other companies.

Mark VellecaBoard DirectorFounded Stridebio +1 Daniel GettsFounder and CEOFounded Cour Pharma Chris JewellAdvisory Board Member (SAB)Founded Nodal Therapeutics

Related companies · 2

BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Eli LillyEli Lilly discovers, develops, manufactures, and markets human pharmaceutical products across cardiometabolic, oncology, immunology, and neuroscience therapeutic areas, selling to healthcare providers and patients in approximately 90 countries through wholesalers, direct sales representatives, and digital platforms.

Companies working in the same space as Create.

Frequently asked questions

What does Create do?: CREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.
Who founded Create?: Create was founded by Daniel Getts in 2020.
Who are Create's investors?: Create's investors include 8VC, Raptor Group, Newpath Partners.
How much funding has Create raised?: Create has disclosed $2M raised across 1 round.
Where is Create headquartered?: Create is headquartered in San Francisco, US.